FCDCX
Price
$32.44
Change
-$0.24 (-0.73%)
Updated
Sep 20 closing price
FSSNX
Price
$27.77
Change
-$0.31 (-1.10%)
Updated
Sep 20 closing price
Ad is loading...

FCDCX vs FSSNX

Header iconFCDCX vs FSSNX Comparison
Open Charts FCDCX vs FSSNXBanner chart's image
Fidelity Advisor Stock Selector Sm Cp C
Price$32.44
Change-$0.24 (-0.73%)
VolumeN/A
CapitalizationN/A
Fidelity Small Cap Index
Price$27.77
Change-$0.31 (-1.10%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FCDCX vs FSSNX Comparison Chart
Loading...
VS
FCDCX vs. FSSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCDCX is a Buy and FSSNX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. FCDCX (3.87B). FSSNX pays higher dividends than FCDCX: FSSNX (1.36) vs FCDCX (0.00). FCDCX was incepted earlier than FSSNX: FCDCX (17 years) vs FSSNX (13 years). FCDCX is a more actively managed with annual turnover of: 38.00 vs. FSSNX (9.00). FCDCX (0) and FSSNX (0) have matching initial minimum investment requirements. FCDCX annual gain was more profitable for investors over the last year : 27.04 vs. FSSNX (22.65). FCDCX return over 5 years is better than : 50.85 vs. FSSNX (44.62).
FCDCXFSSNXFCDCX / FSSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years13 years-
Gain YTD14.9699.972150%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets3.87B27.3B14%
Annual Yield % from dividends0.001.36-
Returns for 1 year27.0422.65119%
Returns for 3 years2.500.65385%
Returns for 5 years50.8544.62114%
Returns for 10 years31.5984.2437%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD3.490.05
+1.45%
Relmada Therapeutics
BSAC20.240.18
+0.90%
Banco Santander-Chile
ODC67.85-0.79
-1.15%
Oil-Dri Corp
HRMY38.34-0.47
-1.21%
Harmony Biosciences Holdings
THAR2.94-0.05
-1.67%
Tharimmune Inc.